{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:59:01Z","timestamp":1794081541714,"version":"4.8.0"},"reference-count":40,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Building Stronger Public Health Institutions and Systems (BIS) (2021-2025) project of the Norwegian Agency for Development Cooperation (NORAD)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>While direct-acting antivirals (DAAs) are available for the treatment of chronic Hepatitis C virus (HCV) patients in Nepal, knowledge of the circulating genotypes\/subtypes and drug target gene mutations of HCV is currently unavailable. Here, we describe HCV genotypes\/subtypes and identify antiviral target gene mutations in patients at a tertiary care hospital using genome data. A cross-sectional study was conducted from December 2019 to February 2024, where PCR followed by whole genome sequencing was performed to identify HCV genotypes\/subtypes and drug target gene mutations. Among all the patients who tested positive for anti-HCV, 70.6% (149\/211) were HCV RNA positive, while 68.2% (30\/44) were genotype\/subtype 3a, followed by 1a (18.2%, 8\/44) and others (13.6%, 6\/44), including new subtypes 3g and 3i from Nepal. Subtype 3a was also the dominant subtype (\u226570%) among intravenous drug users and sexual routes of transmission. We found 70.5% of the samples with resistant mutations in the NS3\/4A region, 22.7% in NS5A, and 45.5% in NS5B. Resistant mutations against sofosbuvir, pibrentasvir, velpatasvir, daclatasvir, and dasabuvir were found at 25%, 18%, 16%, 16%, and 2%, respectively, mostly on subtype 3a. The predominant HCV genotype\/subtype in our patient group was 3a, and resistance mutations against direct-acting antivirals were found in most untreated patients.<\/jats:p>","DOI":"10.3390\/v17030377","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T06:02:13Z","timestamp":1741240933000},"page":"377","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Genotypes\/Subtypes and Antiviral Drug Resistance of the Hepatitis C Virus from Patients in a Tertiary Care Hospital in Nepal"],"prefix":"10.3390","volume":"17","author":[{"given":"Hari Prasad","family":"Kattel","sequence":"first","affiliation":[{"name":"Central Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangita","family":"Sharma","sequence":"additional","affiliation":[{"name":"Tribhuvan University Teaching Hospital, Kathmandu 44601, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-9239","authenticated-orcid":false,"given":"Kristian","family":"Alfsnes","sequence":"additional","affiliation":[{"name":"Norwegian Institute of Public Health, P.O. Box 222, NO-0213 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6665-7492","authenticated-orcid":false,"given":"John H.-O.","family":"Pettersson","sequence":"additional","affiliation":[{"name":"Zoonosis Science Center, Clinical Microbiology, Department of Medical Sciences, Uppsala University, SE-751 05 Uppsala, Sweden"},{"name":"Department of Microbiology, Swedish Veterinary Agency, SE-751 05 Uppsala, Sweden"},{"name":"Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3121, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Pathak","sequence":"additional","affiliation":[{"name":"Tribhuvan University Teaching Hospital, Kathmandu 44601, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serina Beate","family":"Engebretsen","sequence":"additional","affiliation":[{"name":"Norwegian Institute of Public Health, P.O. Box 222, NO-0213 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6281-8236","authenticated-orcid":false,"given":"Komal Raj","family":"Rijal","sequence":"additional","affiliation":[{"name":"Central Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2503-412X","authenticated-orcid":false,"given":"Prakash","family":"Ghimire","sequence":"additional","affiliation":[{"name":"Central Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1614-6747","authenticated-orcid":false,"given":"\u00c5shild K.","family":"Andreassen","sequence":"additional","affiliation":[{"name":"Norwegian Institute of Public Health, P.O. Box 222, NO-0213 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5024-6127","authenticated-orcid":false,"given":"Megha Raj","family":"Banjara","sequence":"additional","affiliation":[{"name":"Central Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2024, December 21). Hepatitis C Fact Sheet. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref_2","unstructured":"Ministry of Health and Population Nepal (2024, December 21). National Guideline for Screening, Care and Treatment of Hepatitis C Infection in Nepal. Available online: https:\/\/www.aidsdatahub.org\/sites\/default\/files\/resource\/nepal-guidelines-hepatitis-2020.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e1254","DOI":"10.1093\/infdis\/jiae253","article-title":"Identification of 2 Novel Subtypes of Hepatitis C Virus Genotype 8 and a Potential New Genotype Successfully Treated with Direct Acting Antivirals","volume":"230","author":"Mbisa","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/infdis\/jiy401","article-title":"Identification of a Novel Hepatitis C Virus Genotype from Punjab, India: Expanding Classification of Hepatitis C Virus into 8 Genotypes","volume":"218","author":"Borgia","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1099\/0022-1317-75-4-931","article-title":"Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group","volume":"75","author":"Tokita","year":"1994","journal-title":"J. Gen. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3855\/jidc.10391","article-title":"Hepatitis C virus genotype and its correlation with viral load in patients from Kathmandu, Nepal","volume":"14","author":"Mishra","year":"2020","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/23744235.2021.1898046","article-title":"High prevalence and genotype distribution of hepatitis C virus in people living with HIV in Kathmandu, Nepal","volume":"53","author":"Poudel","year":"2021","journal-title":"Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1515\/jtim-2017-0007","article-title":"Direct Acting Anti-hepatitis C Virus Drugs: Clinical Pharmacology and Future Direction","volume":"5","author":"Geddawy","year":"2017","journal-title":"J. Transl. Int. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2021.04.045","article-title":"Non-epidemic HCV genotypes in low- and middle-income countries and the risk of resistance to current direct-acting antiviral regimens","volume":"75","author":"Shah","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8910","DOI":"10.3748\/wjg.v22.i40.8910","article-title":"Polymorphisms and resistance mutations of hepatitis C virus on sequences in the European hepatitis C virus database","volume":"22","author":"Kliemann","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/0140-6736(91)92775-W","article-title":"Improvement of HCV genome detection with \u201cshort\u201d PCR products","volume":"338","author":"Garson","year":"1991","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e01491-15","DOI":"10.1128\/mBio.01491-15","article-title":"Virome Capture Sequencing Enables Sensitive Viral Diagnosis and Comprehensive Virome Analysis","volume":"6","author":"Briese","year":"2015","journal-title":"mBio"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/molbev\/msab120","article-title":"MEGA 11: Molecular Evolutionary Genetics Analysis Version 11","volume":"38","author":"Tamura","year":"2021","journal-title":"Mol. Biol. Evol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcv.2016.05.010","article-title":"New findings in HCV genotype distribution in selected West European Russian and Israeli regions","volume":"81","author":"Kartashev","year":"2016","journal-title":"J. Clin. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000481821","article-title":"Distribution of Hepatitis C Virus Genotypes and Subtypes in the Metropolitan Area of Naples, Italy, in the Era of Interferon-Free Regimens","volume":"60","author":"Grimaldi","year":"2017","journal-title":"Intervirology"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bouacida, L., Suin, V., Hutse, V., Boudewijns, M., Cartuyvels, R., Debaisieux, L., De Laere, E., Hallin, M., Hougardy, N., and Lagrou, K. (2018). Distribution of HCV genotypes in Belgium from 2008 to 2015. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0207584"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jvh.12758","article-title":"Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach","volume":"25","author":"Jacka","year":"2018","journal-title":"J. Viral Hepat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4274\/vhd.0013","article-title":"Seven-year Genotype Distribution among Hepatitis C Patients in a City in the Central Anatolia Region of Turkey","volume":"24","author":"Baykan","year":"2018","journal-title":"Viral Hepat. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/MCG.0000000000000872","article-title":"Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States","volume":"53","author":"Gordon","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bjid.2020.06.010","article-title":"Hepatitis C virus genotypes and associated risk factors in the state of Par\u00c3\u00a1 Northern Brazil","volume":"24","author":"Castro","year":"2020","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Pimenov, N., Kostyushev, D., Komarova, S., Fomicheva, A., Urtikov, A., Belaia, O., Umbetova, K., Darvina, O., Tsapkova, N., and Chulanov, V. (2022). Epidemiology and Genotype Distribution of Hepatitis C Virus in Russia. Pathogens, 11.","DOI":"10.20944\/preprints202211.0057.v1"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4274\/vhd.96729","article-title":"A Review of Hepatitis C in the General Population in Pakistan","volume":"22","author":"Riaz","year":"2016","journal-title":"Viral Hepatit. Dergisi."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Sood, A., Suryaprasad, A., Trickey, A., Kanchi, S., Midha, V., Foster, M.A., Bennett, E., Kamili, S., Alvarez-Bognar, F., and Shadaker, S. (2018). The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0200461"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0043-1771182","article-title":"Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh","volume":"10","author":"Rahman","year":"2023","journal-title":"Glob. Med. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.25259\/ijmr_1222_23","article-title":"Hepatitis C virus genotypes among population with reported risk factors in Assam, north-east India: Emergence of genotype-8","volume":"160","author":"Das","year":"2024","journal-title":"Indian J. Med. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12985-015-0341-1","article-title":"Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: Nationwide spread of HCV genotypes 3 and 6","volume":"12","author":"Ju","year":"2015","journal-title":"Virol. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12985-016-0635-y","article-title":"Molecular epidemiology of hepatitis C infections in Ningxia, China: Genotype, phylogeny and mutation analysis","volume":"13","author":"Wu","year":"2016","journal-title":"Virol. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1038\/emi.2017.77","article-title":"Hepatitis C virus genotypes and subtypes circulating in Mainland China","volume":"6","author":"Chen","year":"2017","journal-title":"Emerg. Microbes. Infect."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.virol.2018.01.015","article-title":"Molecular evolution of hepatitis C virus in China: A nationwide study","volume":"516","author":"Huang","year":"2018","journal-title":"Virology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/liv.14011","article-title":"Hepatitis C: Is eradication possible?","volume":"39","author":"Lombardi","year":"2019","journal-title":"Liver Int."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"KC, S., Murphy, H., Dixit, S., Rai, A., Pradhan, B., Lagrange-Xelot, M., Karki, N., Dureault, A., Karmacharya, U., and Panthi, S. (2020). Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal. PLoS Neglected Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008931"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e22726","DOI":"10.1097\/MD.0000000000022726","article-title":"Efficacy and safety of sofosbuvir-based pangenotypic direct-acting antiviral agents for chronic hepatitis C patients without genotype determination: Real-world experience of a retrospective study","volume":"99","author":"Li","year":"2020","journal-title":"Medicine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/hep.29837","article-title":"Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitors","volume":"69","author":"Smith","year":"2019","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100462","DOI":"10.1016\/j.jhepr.2022.100462","article-title":"Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals","volume":"4","author":"Howe","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/cid\/ciae431","article-title":"Prevalence of Drug Resistance Associated Substitutions in Persons with Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment with Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis","volume":"79","author":"Inzaule","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Paolucci, S., Premoli, M., Novati, S., Gulminetti, R., Maserati, R., Barbarini, G., Sacchi, P., Piralla, A., Sassera, D., and Marco, L.D. (2017). Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-15987-1"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Faiz, S., Irfan, M., Farooq, S., Khan, I.A., Iqbal, H., Wahab, A.T., Shakeel, M., Gong, P., Iftner, T., and Choudhary, M.I. (2023). Study of drug resistance-associated genetic mutations, and phylo-genetic analysis of HCV in the Province of Sindh, Pakistan. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-39339-4"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12985-021-01625-w","article-title":"Efficacy and safety of ledipasvir\/sofosbuvir for hepatitis C among drug users: A systematic review and meta-analysis","volume":"18","author":"Yang","year":"2021","journal-title":"Virol. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijid.2021.12.320","article-title":"Frequency distribution of HCV resistance-associated variants in infected patients treated with direct-acting antivirals","volume":"115","author":"Cabral","year":"2022","journal-title":"Int. J. Infect. Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/3\/377\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:48:02Z","timestamp":1760028482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/3\/377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["v17030377"],"URL":"https:\/\/doi.org\/10.3390\/v17030377","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]}}}